Medicine with Active Substance Cerliponaze Alfa Tender - 145121803

Procurement Summary

Country: Slovakia

Summary: Medicine with Active Substance Cerliponaze Alfa 150 Mg, Infusion Solution Description: the Subject of the Order is Medicine with Active Substance Cerliponase Alfa 150 Mg, Infusion Solution Pharmaceutical Form: Sol Inf 5 Ml/150 Mg+5...

Deadline: 25 Jul 2026

Posting Date: 14 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 145121803

Document Ref. No.: 9839 - VST

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: EUR 2678664.6

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

MEDICINE WITH ACTIVE SUBSTANCE CERLIPONAZE ALFA 150 MG, INFUSION SOLUTION Description: The subject of the order is Medicine with active substance cerliponase alfa 150 mg, infusion solution Pharmaceutical form: sol inf 5 ml/150 mg+5 ml prepl. solution (drug.inj.skl.) Administration: intracerebroventricular use The drug cerliponase alfa belongs to a group of drugs known as enzyme replacement therapies. It is used to treat patients with neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. People with with CLN2 disease, they do not have an enzyme called TPP1 or they have too little of it, which causes the accumulation of substances called lysosomal accumulation substances. In people with CLN2 disease, these substances accumulate in some parts of the body, especially in the brain. This medicine replaces the defective an enzyme called TPPA, thereby minimizing the accumulation of lysosomal storage substances. This medicine works by slowing down the progress of the disease. The recommended dose is 300 mg of cerliponase alfa administered once every two weeks intracerebroventricular infusion. Estimated need for the mentioned medicine for 24 months is 360 MJ (180 packs of 2x5ml/150mg+1x5ml prepl. solution or equivalent). By describing the subject of the contract in detail, the public procurer has set the minimum requirements that he wants to comply with for the given subject contracts. In the event that the public procurer used a specific manufacturer, production process, brand, patent, type, country, region or place of origin or production in the description of the subject of the contract, the applicant may, in accordance with § 42 par. 9 of the Public Procurement Act submit an offer also for a technical and functional equivalent. Order type: Goods 4.1.3 Procurement scope Estimated value Estimated value (BT-27-Procedure) (value): 2, 678, 664.6 Estimated value (BT-27-Procedure) (currency): Euro Maximum value framework agreement M...
Estimated value: 2, 678, 664.6

Documents

 Tender Notice